Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Linxweiler

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Cancer Medicine|April 13, 2026
Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland CarcinomasLukas A Brust, Jan Philipp Kühn, Sandrina Körner, et al.
Frontiers in Immunology|June 29, 2023
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patientsMoritz Knebel, Sandrina Körner, Jan Philipp Kühn, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 19, 2022
Cytology-based Cancer Surgery of the Head and Neck (CyCaS-HN): a prospective, randomized, controlled clinical trialMaximilian Linxweiler, Sandrina Körner, Silke Wemmert, et al.
Frontiers in Immunology|July 21, 2025
Case Report: "<i>DEK::AFF2</i> fusion associated sinonasal carcinomas: a novel oncogenic driver and emerging therapeutic strategies"Moritz Knebel, Abbas Agaimy, Jan Philipp Kühn, et al.
Laryngoscope Investigative Otolaryngology|September 1, 2020
Augmented reality-enhanced navigation in endoscopic sinus surgery: A prospective, randomized, controlled clinical trialMaximilian Linxweiler, Lukas Pillong, Dragan Kopanja, et al.
Oncotarget|December 22, 2016
Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomasFlorian Bochen, Hana Adisurya, Silke Wemmert, et al.
Cancer Medicine|February 15, 2025
Optimizing Prognostic Assessment in High-Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring SystemMoritz Knebel, Jan Philipp Kühn, Sandrina Körner, et al.
Cancers|May 4, 2026
Heterogeneity of PD-L1 Expression Between the Primary Tumor and Matched Lymph Node Metastases in Head and Neck Squamous Cell CarcinomasMoritz Knebel, Gilbert Georg Klamminger, Jan Philipp Kühn, et al.
Cancers|September 28, 2021
HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction?Jan Philipp Kühn, Wendelin Schmid, Sandrina Körner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 28, 2024
Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomasLukas A Brust, Maximilian Linxweiler, Jana Schnatmann, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cancer Medicine|April 13, 2026
Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland CarcinomasLukas A Brust, Jan Philipp Kühn, Sandrina Körner, et al.
Frontiers in Immunology|June 29, 2023
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patientsMoritz Knebel, Sandrina Körner, Jan Philipp Kühn, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 19, 2022
Cytology-based Cancer Surgery of the Head and Neck (CyCaS-HN): a prospective, randomized, controlled clinical trialMaximilian Linxweiler, Sandrina Körner, Silke Wemmert, et al.
Frontiers in Immunology|July 21, 2025
Case Report: "<i>DEK::AFF2</i> fusion associated sinonasal carcinomas: a novel oncogenic driver and emerging therapeutic strategies"Moritz Knebel, Abbas Agaimy, Jan Philipp Kühn, et al.
Laryngoscope Investigative Otolaryngology|September 1, 2020
Augmented reality-enhanced navigation in endoscopic sinus surgery: A prospective, randomized, controlled clinical trialMaximilian Linxweiler, Lukas Pillong, Dragan Kopanja, et al.
Oncotarget|December 22, 2016
Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomasFlorian Bochen, Hana Adisurya, Silke Wemmert, et al.
Cancer Medicine|February 15, 2025
Optimizing Prognostic Assessment in High-Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring SystemMoritz Knebel, Jan Philipp Kühn, Sandrina Körner, et al.
Cancers|May 4, 2026
Heterogeneity of PD-L1 Expression Between the Primary Tumor and Matched Lymph Node Metastases in Head and Neck Squamous Cell CarcinomasMoritz Knebel, Gilbert Georg Klamminger, Jan Philipp Kühn, et al.
Cancers|September 28, 2021
HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction?Jan Philipp Kühn, Wendelin Schmid, Sandrina Körner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 28, 2024
Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomasLukas A Brust, Maximilian Linxweiler, Jana Schnatmann, et al.
Pageof 8